Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Singapore Institute of Advanced Medicine Holdings Ltd. ( (SG:9G2) ) has shared an announcement.
Singapore Institute of Advanced Medicine Holdings Ltd. has fully utilised the net proceeds of approximately S$644,000 from its placement of 19,748,000 new shares at S$0.035 each, completed in October 2025, to fund the group’s general working capital needs. The entire amount was applied to maintenance fees for medical equipment, underscoring the capital-intensive nature of its advanced medical operations, and the company also acknowledged an oversight in not promptly announcing the material use of these funds when it occurred in January 2026.
The most recent analyst rating on (SG:9G2) stock is a Hold with a S$0.05 price target. To see the full list of analyst forecasts on Singapore Institute of Advanced Medicine Holdings Ltd. stock, see the SG:9G2 Stock Forecast page.
More about Singapore Institute of Advanced Medicine Holdings Ltd.
Singapore Institute of Advanced Medicine Holdings Ltd., listed on the Catalist board of the Singapore Exchange in February 2024, operates in the medical services industry, focusing on advanced medical diagnostics and treatment supported by specialised medical equipment. The group’s operations require substantial ongoing investment in the maintenance and upkeep of its high-end medical machinery, which is critical to sustaining service quality and clinical capabilities.
Average Trading Volume: 6,061,032
Technical Sentiment Signal: Sell
Current Market Cap: S$65.27M
For detailed information about 9G2 stock, go to TipRanks’ Stock Analysis page.